The Europe Infection Surveillance Solutions Market would witness market growth of 12.2% CAGR during the forecast period (2023-2029).
The development of analytical & infection surveillance solutions for use in the healthcare industry is aided by increased IT system capacity to undertake analytical processing in conjunction with technological improvements in IT systems. Furthermore, the healthcare industry is developing a competent workforce due to various improvements in surveillance solutions that are making it easier for personnel in clinical & healthcare settings to grasp surveillance software and its utilization.
The market is expanding due to the increasing costs of healthcare as well as the high rate of adoption of new IT systems in hospitals for maintaining electronic healthcare records (EHR). The market for infection surveillance solutions also benefits from the growing elderly population and the rising number of surgeries performed globally. In addition, healthcare information & technology (IT) businesses provide cutting-edge solutions for data management, analytics, and infrastructures that make collecting data on diseases and outbreaks easy.
This is accelerating market expansion and several advancements in surveillance solutions that help medical professionals comprehend the software and how to use it. Furthermore, the growing use of cloud-based software and the rising demand for web-based solutions or mobile platforms are further aspects that are anticipated to provide key market players with lucrative growth prospects.
The UK's medical technology industry has a yearly turnover of about $30 billion. It has a solid basis made up primarily of small to medium-sized businesses spread out over the nation, with hubs of activity in places like the Southeast of England & the Midlands. Several major U.S. manufacturers of medical equipment as well as other multinational corporations, have head offices or branches in the UK. Germany is by far the largest European market for medical technology, ranking third in the world. It is projected that these factors will aid in expanding the region's market.
The Germany market dominated the Europe Infection Surveillance Solutions Market by Country in 2022; thereby, achieving a market value of $79.1 Million by 2029. The UK market is exhibiting a CAGR of 11.1% during (2023 - 2029). Additionally, The France market would experience a CAGR of 13.1% during (2023 - 2029).
Based on Product & Services, the market is segmented into Software (On-premise and Web-based Software) and Services. Based on End User, the market is segmented into Hospitals, Long-term Care Facilities and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Infection Surveillance Solutions Market is Projected to reach USD 1.3 Billion by 2029, at a CAGR of 12.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMérieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
By Product & Services
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
